Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery
NCT02170935
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Venous Thromboembolism
Interventions
DRUG:
BIBR 1048 capsule
Sponsor
Boehringer Ingelheim